MedPath

To assess the effect of Homoeopathic mother tincture Chelidonium majus in cases of Non Alcoholic Fatty Liver Disease with Dyslipidemia (excess cholesterol).

Phase 3
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Registration Number
CTRI/2022/01/039490
Lead Sponsor
Changlani sagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with grade I, grade II and grade III nonalcoholic fatty liver disease will be

considered.

2.Patients with known case of type 2 diabetes mellitus who are on conventional treatments

with HbA1c not more than 8%.

3.Patients who have willingly join the study and signed the written informed consent

Exclusion Criteria

1.Patients who have alcoholic fatty liver disease

2.Patient who has been diagnose with Viral hepatitis or auto immune hepatitis

3.Patients who have any other metabolic disease like Hereditary hemochromatosis,

Alpha 1 antitrypsin deficiency , Wilson disease, Uncontrolled thyroid disease

4.Patients who are diagnosed with liver disease due to any other etiology

5.Patient with active cardio pulmonary manifestations.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath